(Q44281189)

1 December 2017

title

Parkin gene alterations in ovarian carcinoma from northern Indian population (English)

1 reference

1 December 2017

1 reference

Syed Jafar Mehdi

1

1 reference

1 December 2017

Asgar Ali

series ordinal

2

1 reference

1 December 2017

M Moshahid Alam Rizvi

series ordinal

3

1 reference

1 December 2017

publication date

10 January 2011

1 reference

Pathology Oncology Research

1 December 2017

published in

1 reference

1 December 2017

volume

17

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

579-586

1 reference

https://scigraph.springernature.com/pub.10.1007/s12253-010-9351-x

1 December 2017

exact match

0 references

cites work

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

Allelic gains and losses in distinct regions of chromosome 6 in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

Chromosome 6 suffers frequent and multiple aberrations in thymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

Suppression of tumorigenicity in human ovarian cancer cell lines is controlled by a 2 cM fragment in chromosomal region 6q24-q25.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

Complex relationship between Parkin mutations and Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

Alterations in the common fragile site gene Parkin in ovarian and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

Parkin gene alterations in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-010-9351-X

3 distinct regions of chromosome-6 are targets of loss of heterozygosity in human ovarian carcinomas

21 January 2018

1 reference

12 December 2020

Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer

1 reference

12 December 2020

Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization

1 reference

12 December 2020

Loss of heterozygosity at 6q is frequent and concurrent with 3p loss in sporadic and familial capillary hemangioblastomas

1 reference

12 December 2020

Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer

1 reference

12 December 2020

Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization

1 reference

12 December 2020

MSI/LOH and extron expression of the FHIT gene in gastric carcinoma

1 reference

12 December 2020

Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas

1 reference

12 December 2020

A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer

1 reference

12 December 2020

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology

1 reference

12 December 2020

Deletion of 6q16-q21 in human lymphoid malignancies: a mapping and deletion analysis

1 reference

12 December 2020

Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA-FISH

1 reference

12 December 2020

Physical map of the D6S149-D6S193 region on chromosome 6Q27 and its involvement in benign surface epithelial ovarian tumours

1 reference

12 December 2020

Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma.

1 reference

12 December 2020

Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization

1 reference

12 December 2020

Early involvement of 6q in surface epithelial ovarian tumors.

1 reference

12 December 2020

Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors

1 reference

12 December 2020

A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas

1 reference

12 December 2020

10.1007/S12253-010-9351-X

Identifiers

DOI

1 reference

1 December 2017

1 reference